Acquisition of a new NMR spectrometer for studying molecules important to health
Acquisition of a 400 MHz NMR Spectrometer
This study is about getting a new, advanced NMR machine to help researchers at Vanderbilt University better understand small molecules that can improve human health, which could lead to new treatments and discoveries in medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10851522 on NIH RePORTER |
What this research studies
This research focuses on acquiring a modern 400 MHz NMR spectrometer to replace an outdated instrument used for studying small molecules relevant to human health. The new spectrometer will enhance the capabilities of various research groups at Vanderbilt University, allowing them to conduct advanced studies in areas such as chemical synthesis, glycoscience, and natural products discovery. By providing improved technology, the research aims to support innovative biomedical research that can lead to better understanding and treatment of health-related issues.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals involved in or affected by conditions that require advanced biochemical analysis and drug development.
Not a fit: Patients who are not engaged in research or do not have conditions that involve molecular studies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in the understanding of molecular interactions that are crucial for developing new therapies and treatments.
How similar studies have performed: Other research initiatives utilizing modern NMR technology have shown significant success in advancing our understanding of molecular biology and chemistry.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Schley, Nathan David — Vanderbilt University
- Study coordinator: Schley, Nathan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.